New York State Common Retirement Fund Genfit S.A. Transaction History

New York State Common Retirement Fund

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 07, 2020	SELL	$5.2 - $22.0 $64,636 - $273,460	-12,430 Closed	0 $0
Q1 2020 May 06, 2020	BUY	$10.95 - $20.76 $1,095 - $2,076	100 Added 0.81%	12,430 $179,000
Q3 2019 Nov 07, 2019	BUY	$14.92 - $19.94 $25,364 - $33,898	1,700 Added 15.99%	12,330 $215,000
Q2 2019 Aug 09, 2019	SELL	$19.74 - $25.65 $9,870 - $12,825	-500 Reduced 4.49%	10,630 $210,000
Q1 2019 May 08, 2019	BUY	$22.17 - $24.0 $246,752 - $267,120	11,130 New	11,130 $267,000

49.2K

Ticker GNFT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,815,500
Market Cap $274M
Description
Genfit S.A., a biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. The company's products include Elafibranor, which is in Phase 3 clinical trial to treat patients with primary biliary cholangitis. It also engages in the development of NIS4 technology for the diagno...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.